13.15
Schlusskurs vom Vortag:
$13.00
Offen:
$13.18
24-Stunden-Volumen:
3.11M
Relative Volume:
0.39
Marktkapitalisierung:
$3.92B
Einnahmen:
$11.70B
Nettoeinkommen (Verlust:
$-442.90M
KGV:
-7.5128
EPS:
-1.751
Netto-Cashflow:
$1.06B
1W Leistung:
-4.96%
1M Leistung:
-1.98%
6M Leistung:
-31.95%
1J Leistung:
+2.13%
Oscar Health Inc Stock (OSCR) Company Profile
Firmenname
Oscar Health Inc
Sektor
Branche
Telefon
(646) 403-3677
Adresse
75 VARICK STREET, NEW YORK
Compare OSCR vs UNH, CVS, CI, ELV, HUM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
OSCR
Oscar Health Inc
|
13.16 | 3.87B | 11.70B | -442.90M | 1.06B | -1.751 |
|
UNH
Unitedhealth Group Inc
|
282.02 | 251.47B | 447.57B | 12.81B | 16.08B | 13.19 |
|
CVS
Cvs Health Corp
|
76.70 | 96.78B | 402.11B | 1.73B | 7.81B | 1.3835 |
|
CI
Cigna Group
|
268.10 | 70.07B | 274.88B | 6.29B | 8.39B | 22.19 |
|
ELV
Elevance Health Inc
|
292.49 | 63.54B | 199.13B | 5.66B | 3.17B | 25.11 |
|
HUM
Humana Inc
|
165.98 | 19.65B | 126.36B | 1.30B | 1.55B | 10.67 |
Oscar Health Inc Stock (OSCR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-12 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2026-01-09 | Hochstufung | UBS | Sell → Neutral |
| 2026-01-05 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2025-12-11 | Eingeleitet | Stephens | Equal-Weight |
| 2025-11-26 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2025-10-14 | Eingeleitet | Goldman | Neutral |
| 2025-07-25 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-07-15 | Herabstufung | UBS | Neutral → Sell |
| 2025-07-14 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-07-11 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2025-07-02 | Eingeleitet | Barclays | Underweight |
| 2025-06-24 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2025-03-13 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-12-10 | Eingeleitet | Jefferies | Underperform |
| 2024-11-06 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-10-07 | Eingeleitet | UBS | Neutral |
| 2024-06-26 | Eingeleitet | Piper Sandler | Overweight |
| 2024-05-30 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-03-22 | Eingeleitet | Raymond James | Outperform |
| 2023-11-02 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-06-06 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-11-16 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2022-11-14 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-06-15 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-05-26 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-02-14 | Herabstufung | Goldman | Neutral → Sell |
| 2022-01-06 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2021-12-14 | Eingeleitet | Goldman | Sell |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-03-30 | Eingeleitet | Wells Fargo | Overweight |
| 2021-03-29 | Eingeleitet | BofA Securities | Buy |
| 2021-03-29 | Eingeleitet | Cowen | Market Perform |
| 2021-03-29 | Eingeleitet | Credit Suisse | Outperform |
| 2021-03-29 | Eingeleitet | Goldman | Buy |
| 2021-03-29 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Oscar Health Inc Aktie (OSCR) Neueste Nachrichten
Oscar Health, Inc. (NYSE:OSCR) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Oscar Health Valuation After Raymond James Upgrade And Margin Expansion Outlook - simplywall.st
Oscar Health, Inc. (OSCR) Experiences Sharper Decline Compared to Overall Market: Key Information for Investors - Bitget
Oscar Health, Inc. (OSCR) Falls More Steeply Than Broader Market: What Investors Need to Know - Yahoo Finance
Raymond James Upgrades Oscar Health, Inc. (OSCR), UBS Lowers PT - Insider Monkey
Time To Buy The Dip In Oscar Health Stock? - Trefis
Employer model comes under pressure as ICHRAs offer new options, Oscar Health argues - Traders Union
(OSCR) and the Role of Price-Sensitive Allocations - Stock Traders Daily
How Reaffirmed 2026 Outlook and Surging Membership Will Impact Oscar Health (OSCR) Investors - Sahm
Oscar Health’s CEO Says 2026 Is the Year It Finally Turns a Profit — Here’s What He’s Betting On - Yahoo Finance
Did Oscar’s Reaffirmed 2026 Outlook and Reinsurance Strategy Just Shift Oscar Health's (OSCR) Investment Narrative? - Yahoo Finance
Neo Ivy Capital Management Increases Stake in Oscar Health, Inc. $OSCR - MarketBeat
A Look At Oscar Health’s Valuation After Reaffirmed 2026 Guidance At Raymond James Conference - Sahm
April 24th Options Now Available For Oscar Health (OSCR) - Nasdaq
Oscar Health (OSCR +10%): Delayed Reaction to Confident 2026 Outlook - Trefis
Oscar Health, Inc. (OSCR) Crossed Above the 50-Day Moving Average: What That Means for Investors - Yahoo Finance
TD Asset Management Inc Has $2.32 Million Stock Holdings in Oscar Health, Inc. $OSCR - MarketBeat
Oscar Health chief accounting officer Baltrus sells $62k in stock - Investing.com Nigeria
Oscar Health (OSCR) president granted 106,458 RSUs and sells 7,453 shares - Stock Titan
Oscar Health (OSCR) CAO awarded 17,300 RSUs and sells shares for taxes - Stock Titan
Oscar Health (OSCR) CLO awarded 67,424 RSUs and sells 18,710 shares - Stock Titan
Oscar Health (OSCR) CTO gets major RSU grant and sells shares for taxes - Stock Titan
Oscar Health (OSCR) CFO awarded RSUs and sells 19,221 shares - Stock Titan
Oscar Health (NYSE:OSCR) Shares Up 10%Here's Why - MarketBeat
Oscar Health Inc (OSCR) Trading 4.79% Higher on Mar 4 - GuruFocus
OSCR Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Oscar Health, Inc. $OSCR Stock Holdings Decreased by Glynn Capital Management LLC - MarketBeat
Oscar Health, Inc. $OSCR Position Raised by American Century Companies Inc. - MarketBeat
OSCR SEC FilingsOscar Health Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Rule 144 notice: 14,168 RSUs set to vest and resale (OSCR) - Stock Titan
Oscar Health at Raymond James Conference: Navigating ACA Complexities By Investing.com - Investing.com Canada
Oscar Health, Inc. (OSCR) Investor Outlook: Navigating a Potential 12.9% Upside Amid Mixed Analyst Ratings - DirectorsTalk Interviews
Oscar Health Reaffirms 2026 Outlook at Investor Conference - TipRanks
Oscar to Reaffirm 2026 Full-Year Guidance at Raymond James Conference - TradingView
Oscar Health (NYSE: OSCR) backs 2026 outlook at Raymond James event - Stock Titan
Affiliate plans sale of 54,850 shares by insider (OSCR) - Stock Titan
Oscar Health (OSCR) Reports $11.7B in 2025 Revenue Amid Strong Membership Growth - Insider Monkey
How Is The Market Feeling About Oscar Health Inc? - Benzinga
Here is What to Know Beyond Why Oscar Health, Inc. (OSCR) is a Trending Stock - Yahoo Finance
Vanguard Group Inc. Acquires 423,184 Shares of Oscar Health, Inc. $OSCR - MarketBeat
Here’s What You Should Understand Besides the Reasons Oscar Health, Inc. (OSCR) is Gaining Attention - Bitget
Should Options Spike and ACA Policy Jitters Require Action From Oscar Health (OSCR) Investors? - Sahm
Assessing Oscar Health (OSCR) Valuation After Recent Weak Share Price Performance - Yahoo Finance
Oscar Health Tumbles: Can This Insurtech Disruptor Bounce Back? - Forbes
Longleaf Partners Small-Cap Fund’s Investment in Oscar Health (OSCR) Paid Off - Insider Monkey
Oscar Health Stock Tumbled 22% – Opportunity or Trap? - Trefis
Is 21.7% Fall In Oscar Health (OSCR) Stock A Buying Opportunity? - Trefis
Oscar Health (OSCR) Sees Increase in Bullish Options Activity - GuruFocus
Oscar Health, Inc. (OSCR) Stock Analysis: Navigating a 16.4% Potential Upside Amidst Market Volatility - DirectorsTalk Interviews
Medpace, Revvity, Azenta, Bio-Techne, and Oscar Health Stocks Trade Down, What You Need To Know - TradingView
Oscar Health (NYSE:OSCR) Slides on NYSE Composite Indices Earnings - Kalkine Media
Finanzdaten der Oscar Health Inc-Aktie (OSCR)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):